R4 Ballot #1 (Mixed Normative/Trial use)

This page is part of the FHIR Specification (v3.3.0: R4 Ballot 2). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3

Medicationadministration0304.json

Pharmacy Work GroupMaturity Level: N/ABallot Status: InformativeCompartments: Device, Encounter, Patient, Practitioner, RelatedPerson

Raw JSON (canonical form)

Intravenous Chemotherapy (Inpatient order) - Alemtuzumab - completed

{
  "resourceType": "MedicationAdministration",
  "id": "medadmin0304",
  "text": {
    "status": "generated",
    "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative with Details</b></p><p><b>id</b>: medadmin0304</p><p><b>contained</b>: </p><p><b>status</b>: completed</p><p><b>medication</b>: id: med0303; Alemtuzumab 10mg/ml (Lemtrada) <span>(Details : {RxNorm code '1594660' = 'alemtuzumab 10 MG/ML [Lemtrada]', given as 'Alemtuzumab 10mg/ml (Lemtrada)'})</span></p><p><b>subject</b>: <a>Donald Duck</a></p><p><b>context</b>: <a>encounter who leads to this prescription</a></p><p><b>effective</b>: 15/01/2015 4:30:00 AM --&gt; 15/01/2015 2:30:00 PM</p><h3>Performers</h3><table><tr><td>-</td><td><b>Actor</b></td></tr><tr><td>*</td><td><a>Patrick Pump</a></td></tr></table><p><b>reasonReference</b>: <a>Condition/f202</a></p><p><b>request</b>: <a>MedicationRequest/medrx0319</a></p><h3>Dosages</h3><table><tr><td>-</td><td><b>Text</b></td><td><b>Route</b></td><td><b>Method</b></td><td><b>Dose</b></td></tr><tr><td>*</td><td>Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk</td><td>Intravenous route (qualifier value) <span>(Details : {SNOMED CT code '47625008' = 'Intravenous route', given as 'Intravenous route (qualifier value)'})</span></td><td>Inject - dosing instruction imperative (qualifier value) <span>(Details : {SNOMED CT code '422145002' = 'Inject', given as 'Inject - dosing instruction imperative (qualifier value)'})</span></td><td>3 mg<span> (Details: UCUM code mg = 'mg')</span></td></tr></table></div>"
  },
  "contained": [
    {
      "resourceType": "Medication",
      "id": "med0303",
      "code": {
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "1594660",
            "display": "Alemtuzumab 10mg/ml (Lemtrada)"
          }
        ]
      }
    }
  ],
  "status": "completed",
  "medicationReference": {
    "reference": "#med0303"
  },
  "subject": {
    "reference": "Patient/pat1",
    "display": "Donald Duck"
  },
  "context": {
    "reference": "Encounter/f001",
    "display": "encounter who leads to this prescription"
  },
  "effectivePeriod": {
    "start": "2015-01-15T04:30:00+01:00",
    "end": "2015-01-15T14:30:00+01:00"
  },
  "performer": [
    {
      "actor": {
        "reference": "Practitioner/f007",
        "display": "Patrick Pump"
      }
    }
  ],
  "reasonReference": [
    {
      "reference": "Condition/f202"
    }
  ],
  "request": {
    "reference": "MedicationRequest/medrx0319"
  },
  "dosage": {
    "text": "Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk",
    "route": {
      "coding": [
        {
          "system": "http://snomed.info/sct",
          "code": "47625008",
          "display": "Intravenous route (qualifier value)"
        }
      ]
    },
    "method": {
      "coding": [
        {
          "system": "http://snomed.info/sct",
          "code": "422145002",
          "display": "Inject - dosing instruction imperative (qualifier value)"
        }
      ]
    },
    "dose": {
      "value": 3,
      "unit": "mg",
      "system": "http://unitsofmeasure.org",
      "code": "mg"
    }
  }
}

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.